Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis M Weiner

Showing results (21-30 of 133) with videos related to

Pageof 14
Sort By:
Cancers|January 27, 2021
Understanding and Targeting Natural Killer Cell-Cancer-Associated Fibroblast Interactions in Pancreatic Ductal AdenocarcinomaZoe X Malchiodi, Louis M Weiner
Cancer Prevention Research (Philadelphia, Pa.)|March 25, 2010
Vaccine prevention of cancer: can endogenous antigens be targeted?Louis M Weiner, Rishi Surana, Joseph Murray
Briefings in Functional Genomics|May 16, 2018
Functional genomics: paving the way for more successful cancer immunotherapyReham Ajina, Danielle Zamalin, Louis M Weiner
Nature Reviews. Immunology|April 24, 2010
Monoclonal antibodies: versatile platforms for cancer immunotherapyLouis M Weiner, Rishi Surana, Shangzi Wang
Seminars in Cancer Biology|January 17, 2012
Monoclonal antibodies for the treatment of cancerCasey W Shuptrine, Rishi Surana, Louis M Weiner
Clinical Colorectal Cancer|December 13, 2005
Overview of monoclonal antibodies and small molecules targeting the epidermal growth factor receptor pathway in colorectal cancerLorraine C Snyder, Igor Astsaturov, Louis M Weiner
Nature Reviews. Clinical Oncology|October 1, 2014
The development of immunoconjugates for targeted cancer therapyBrandon G Smaglo, Dalal Aldeghaither, Louis M Weiner
Journal of Clinical Pharmacology|February 25, 2015
Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructsDalal AlDeghaither, Brandon G Smaglo, Louis M Weiner
Lancet (London, England)|March 24, 2009
Monoclonal antibodies for cancer immunotherapyLouis M Weiner, Madhav V Dhodapkar, Soldano Ferrone
Cancers|December 31, 2020
3D Culture Systems for Exploring Cancer ImmunologyAllison A Fitzgerald, Eric Li, Louis M Weiner
Pageof 14

Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
Cancers|January 27, 2021
Understanding and Targeting Natural Killer Cell-Cancer-Associated Fibroblast Interactions in Pancreatic Ductal AdenocarcinomaZoe X Malchiodi, Louis M Weiner
Cancer Prevention Research (Philadelphia, Pa.)|March 25, 2010
Vaccine prevention of cancer: can endogenous antigens be targeted?Louis M Weiner, Rishi Surana, Joseph Murray
Briefings in Functional Genomics|May 16, 2018
Functional genomics: paving the way for more successful cancer immunotherapyReham Ajina, Danielle Zamalin, Louis M Weiner
Nature Reviews. Immunology|April 24, 2010
Monoclonal antibodies: versatile platforms for cancer immunotherapyLouis M Weiner, Rishi Surana, Shangzi Wang
Seminars in Cancer Biology|January 17, 2012
Monoclonal antibodies for the treatment of cancerCasey W Shuptrine, Rishi Surana, Louis M Weiner
Clinical Colorectal Cancer|December 13, 2005
Overview of monoclonal antibodies and small molecules targeting the epidermal growth factor receptor pathway in colorectal cancerLorraine C Snyder, Igor Astsaturov, Louis M Weiner
Nature Reviews. Clinical Oncology|October 1, 2014
The development of immunoconjugates for targeted cancer therapyBrandon G Smaglo, Dalal Aldeghaither, Louis M Weiner
Journal of Clinical Pharmacology|February 25, 2015
Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructsDalal AlDeghaither, Brandon G Smaglo, Louis M Weiner
Lancet (London, England)|March 24, 2009
Monoclonal antibodies for cancer immunotherapyLouis M Weiner, Madhav V Dhodapkar, Soldano Ferrone
Cancers|December 31, 2020
3D Culture Systems for Exploring Cancer ImmunologyAllison A Fitzgerald, Eric Li, Louis M Weiner
Pageof 14